VERSANT HCV Genotype 2.0 Assay (LiPA)* by Siemens Healthineers

Optimize your laboratory’s testing with the widely used VERSANT^® HCV Genotype 2.0 Assay (LiPA). LiPA utilizes reverse-hybridization technology to detect HCV genotypes 1–6 and common subtypes (varies by region). LiPA provides highly accurate identification of HCV genotypes and subtypes for optimal and personalized patient therapy.

*LiPA is FDA-approved for IVD use in the U.S and CE-marked for IVD use in the EU.